Merck & Co. and Hanwha Chemical to Develop Biosimilar Candidate

06:00 AM | June 14, 2011 | Deepti Ramesh

Merck & Co. (Whitehouse Station, NJ) says it has entered into an exclusive global agreement with Hanwha Chemical (Seoul) to develop and commercialize a candidate biosimilar form of Enbrel (etanercept)...